Akitoshi Douhara

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

Kosuke Kaji, Hitoshi Yoshiji, Yasuhide Ikenaka et al. · Journal of Gastroenterology · 2013 · 130 citations

Liver Fibrosis, Pathology, Hepatic Fibrosis +16

Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis

Masanori Furukawa, Kei Moriya, Jiro Nakayama et al. · Hepatology Research · 2020 · 76 citations

Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model

Akitoshi Douhara, Kei Moriya, Hitoshi Yoshiji et al. · Molecular Medicine Reports · 2014 · 73 citations · Full text

Intestinal Permeability, Liver Fibrosis, Dysbiosis +29

Cross talk between toll‐like receptor‐4 signaling and angiotensin‐II in liver fibrosis development in the rat model of non‐alcoholic steatohepatitis

Yusaku Shirai, Hitoshi Yoshiji, Ryuichi Noguchi et al. · Journal of Gastroenterology and Hepatology · 2013 · 47 citations

Ipragliflozin, a sodium–glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long–Evans Tokushima fatty rats

Norihisa Nishimura, Mitsuteru Kitade, Ryuichi Noguchi et al. · Journal of Gastroenterology · 2016 · 43 citations

Inflammation, Metabolic Syndrome, Sodium–glucose Cotransporter 2 +11